Followers | 510 |
Posts | 81956 |
Boards Moderated | 10 |
Alias Born | 07/22/2009 |
Friday, April 11, 2014 9:03:58 AM
Download PDF
LOS ANGELES, CA -- (Marketwired) -- 04/11/14 -- MediSwipe, Inc. (www.MediSwipe.com) (OTCQB: MWIP), a fully reporting company on the OTCQB, a leader in Compassionate Care Technology and indoor/outdoor agricultural solutions for the medicinal marijuana industry, today announced that the Company has expanded its corporate presence in Denver, Colorado to now include 7,500 sq. ft. of office space for a multi-year term. The new offices located within the Cherry Creek subdivision and office complex will include sharing the space with an established, Colorado based oncology clinical trial and drug testing company and facility presently doing cancer research and testing for established pharmaceutical companies seeking FDA approval for new drugs.
"We have obviously begun to make a substantial commitment and investment within the state of Colorado with our previously announced agreements for ownership interests of approximately one-hundred and sixty acres zoned for agricultural use and the build out of our two managed green house facilities. It was quite opportunistic for us to find this amount of executive office space cost effectively which will allow us to expand our onsite management and sales team beginning this month. At the same time, we have found a potential synergistic partner within the oncology and pharmaceutical testing side that could provide a value added service to our clients and patients," stated B. Michael Friedman, CEO of MediSwipe.
"We believe the testing facility could create an extremely valuable vertical service by giving our tenants from the green house farms the ability to test harvests providing insightful data on THC and CBD levels of medicine once proper licensing by the state is granted to our partners as a private, licensed Colorado based testing facility. MediSwipe could provide the ability to store all results and analytical data on our cloud based system on behalf of the testing facility, tracking the quality and consistency of medicine and provide documented data of patient progress from multiple strains both THC and CBD specific on behalf of the state licensed facility once approved," added Friedman.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM